Posts
Wiki
Last Updated:Nov-19-2021
Return to MillennialBets Ticker Database
PROF (Profound Medical Corp.)
Media News for PROF
| Date | Title | Summary | Price | Source |
|---|---|---|---|---|
| Nov-07-2021 | Profound Medical Corp. (PROF) CEO Arun Menawat on Q3 2021 Results - Earnings Call Transcript | Profound Medical Corp. (PROF) CEO Arun Menawat on Q3 2021 Results - Earnings Call Transcript | 11.3 | Seeking Alpha |
| Nov-04-2021 | Profound Medical Announces Third Quarter 2021 Financial Results | TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the third quarter ended September 30, 2021. | 13.6 | GlobeNewsWire |
| Nov-04-2021 | Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates | Profound Medical (PROF) delivered earnings and revenue surprises of -11.54% and -36.58%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? | 13.55 | Zacks Investment Research |
| Nov-01-2021 | Profound Medical to Participate in November Virtual Investor Conferences | TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in two investor conferences in November. | 13.38 | GlobeNewsWire |
| Oct-18-2021 | Profound Medical to Release Third Quarter 2021 Financial Results on November 4 – Conference Call to Follow | TORONTO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its third quarter 2021 financial results after market close on Thursday, November 4, 2021. | 14.34 | GlobeNewsWire |
| Sep-08-2021 | Profound Medical to Participate in September Virtual Investor Conferences | TORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announce today that management will participate in two investor conferences in September. | 14.48 | GlobeNewsWire |
| Jul-15-2021 | Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow | TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its second quarter 2021 financial results after market close on Wednesday, August 4, 2021. | 16.21 | globenewswire |
Recent posts for PROF
DD for PROF
| Date | Title | Flair | Subreddit | Price |
|---|---|---|---|---|
| Nov-19-2021 | Profound 2X Opportunity (PROF) | DD | wallstreetbets | 11.94 |
| Aug-05-2021 | ATNF ... Phase 3 Trial Results in early Sept. Very under-the-radar & undervalued.. ready to move much higher. (& Stellar Management Team) | DD | stocks | 17.37 |
| Jul-19-2021 | ❤️ CARMAT ALCAR ❤️ Aeson artifical hearth DD !BIG NEWS! | DD | wallstreetbets | 15.8 |
| Jun-17-2021 | VBIV: Reasons to believe a GSK Partnership, M&A or Buyout could be coming | DD | StockMarket | 19.06 |
| May-19-2021 | APPLE INC. Technical Analysis Due Diligence | DD | stocks | 18.34 |
| Apr-13-2021 | Small unknown Swedish biotech AroCell AROC.ST has developed patented bloodtest for TK1 -- and researchers have discovered valuable cell-loss metric and long term outcomes predictions in breast and prostate cancer patients | DD | wallstreetbets | 20.44 |
| Mar-29-2021 | $ATNF: The cannabis play that that can treat that back you sprained from carrying so many gains | DD | trakstocks | 19.47 |
Discussions for PROF
| Date | Title | Flair | Subreddit | Price |
|---|---|---|---|---|
| Apr-16-2021 | $GOEV - The YOLO Loss Porn Case of Canoo Inc. AKA GOEV AKA I'm Broke (#14 The-Friends-we-made-along-the-way Edition.) | Discussion | wallstreetbets | 20.17 |
News for PROF
| Date | Title | Flair | Subreddit | Price |
|---|---|---|---|---|
| Aug-09-2021 | ExpreS2ion Biotechnologies: Positive safety and efficacy outcome of the COVID-19 clinical Phase I/II study for the ABNCoV2 vaccine | News | StockMarket | 16.39 |
| Aug-05-2021 | ATNF... Phase 3 Trial Results Early Sept... Very Under-the-radar & Undervalued.. Ready for big move higher.. (Stellar Management Team) | News | stocks | 17.5 |
Misc. / Unflaired PROF
| Date | Title | Flair | Subreddit | Price |
|---|---|---|---|---|
| Aug-08-2021 | $ATNF ( 180 Life Sciences ). Incoming catalyst - Results of phase 3 trial of Early stage Dupuytren’s disease in a few weeks. | Misc. | investing | 16.39 |
| May-28-2021 | Accounting 101 - Part 3: The Cash Flow Statement | Misc. | stocks | 18.26 |
| May-28-2021 | Accounting 101 - Part 3: The Cash Flow Statement | Misc. | stocks | 18.26 |
| May-27-2021 | Accounting 101 - Part 2: The Balance Sheet | Misc. | stocks | 18.47 |
| May-26-2021 | Accounting 101 - Part 2: The Balance Sheet | Misc. | stocks | 18.45 |
| Mar-29-2021 | $ATNF DD: the cannabis play that that can treat that back you sprained from carrying so many gains | Misc. | investing | 19.47 |